Measuring Satisfaction with Migraine Treatment: Expectations, Importance, Outcomes, and Global Ratings

Clinical Therapeutics

Volumn 25, Issue 11, 2003, Pages 2920-2935

  Patrick, Donald L ^a,d   Martin, Mona L ^b   Bushnell, Donald M ^b   Pesa, Jacqueline ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Health Research Associates Inc   (United States)

^c ASTRAZENECA   (United Kingdom)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Migraine; Patient satisfaction; Therapy

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BIOMETRY; CLINICAL ARTICLE; CONCEPTUAL MODEL; DISEASE SEVERITY; DRUG DOSE; DRUG USE; EASE OF USE; FEMALE; FORM 36 ITEM HEALTH SURVEY; GLOBAL RATING; HUMAN; LIFE EVENT; MALE; MIGRAINE; MIGRAINE INTENSITY; MIGRAINE QUALITY OF LIFE QUESTIONNAIRE; MIGRAINE TREATMENT SATISFACTION MEASURE; MODEL; PAIN ASSESSMENT; PATIENT ATTITUDE; PATIENT SATISFACTION; QUESTIONNAIRE; RATING SCALE; RECURRENT DISEASE; SCORING SYSTEM; STATISTICAL ANALYSIS; SYMPTOM BOTHERSOMENESS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0344233249     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)80345-4     Document Type: Article

References (30)

1. Patrick DL, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York: Oxford University Press; 1993.
2. Weaver M, Patrick DL, Markson LE, et al. Issues in the measurement of satisfaction with treatment. Am J Manag Care. 1997;3:579-594.
3. Hall JA, Millburn MA, Epstein AM. A causal model of health status and satisfaction with medical care. Med Care. 1993;31:84-94.
4. Yi Y. A critical review of consumer satisfaction. In: Zeithaml V, ed. Review of Marketing. Chicago, Ill: American Marketing Association; 1990:68-123.
5. Oliver RL. Satisfaction: A Behavioral Perspective on the Consumer. New York: McGraw-Hill; 1997.
6. Stimson G, Webb B. Going to See the Doctor: The Consultation Process in General Practice. London, UK: Routledge and Kegan Paul; 1975.
7. Locker D, Dunt D. Theoretical and methodological issues in sociological studies of consumer satisfaction with medical care. Soc Sci Med. 1978;12:283-292.
8. Parasuraman A, Berry LL, Zeithaml VA. SERVQUAL: A multiple-item scale for measuring customer perceptions of service quality. J Retailing. 1988;64:12-40.
9. Parasuraman A, Berry L, Zeithaml V. Guidelines for conducting service quality research. Marketing Res. 1990:34-44.
10. Linder-Pelz S. Social psychological determinants of patient satisfaction: A test of five hypotheses. Soc Sci Med. 1982;16:583-589.
11. Bradley C, Lewis KS. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes. Diabet Med. 1990;7:445-451.
12. Lubeck DP, Litwin MS, Henning JM, et al. An instrument to measure patient satisfaction with healthcare in an observational database: Results of a validation study using data from CaPSURE. Am J Manag Care. 2000;6:70-76.
13. Mathias SD, Warren EH, Colwell HH, Sung JC. A new treatment satisfaction measure for asthmatics: A validation study. Qual Life Res. 2000;9:873-882.
14. Goldstein J, Ryan R, Jiang K, et al. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group. Headache. 1998;38:737-747.
15. Powers C, Szeto S, Pangtay D, et al. Evaluation of migraineurs' preference for naratriptan over conventional first-line agents. Arch Fam Med. 2000;9:753-758.
16. Gerth W, McCarroll K, Santanello N, et al. Patient satisfaction with rizatriptan versus other triptans: Direct head-to-head comparisons. Int J Clin Pract. 2001;55:552-556.
17. Pascual J, Bussone G, Hernandez J, et al. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine. Eur Neurol. 2001;45:275-283.
18. Davis K, Black L, Sleath B. Validation of the Patient Perception of Migraine Questionnaire. Value Health. 2002;5:421-429.
19. Colman S, Brod M, Krishnamurthy A, et al. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan. Clin Ther. 2001;23:127-145.
20. Savani N, Pfaffenrath V, Rice L, et al. Efficacy, tolerability and patient satisfaction with 50- and 100-mg sumatriptan tablets in those initially dissatisfied with the efficacy of 50-mg sumatriptan tablets. Clin Ther. 2001;23:260-271.
21. Bouchard J, Cortelli P, Dahlof C, et al. A multinational investigation of the impact of subcutaneous sumatriptan. IV: Patient satisfaction. PharmacoEconomics. 1997;11(Suppl 1):43-50.
22. Adelman JU, Sharfman M, Johnson R, et al. Impact of oral sumatriptan on workplace productivity, health-related quality of life, healthcare use, and patient satisfaction with medication in nurses with migraine. Am J Manag Care. 1996;2:1407-1416.
23. Caro G, Caro J, O'Brien J, et al. Migraine therapy: Development and testing of a patient preference questionnaire. Headache. 1998;38:602-607.
24. Hudak PL, Wright JG. The characteristics of patient satisfaction measures. Spine. 2000;25:3167-3177.
25. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.
26. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of new quality of life questionnaire for acute migraine headache. Headache. 1995;35:330-337.
27. Hartmaier SL, Santanello NC, Epstein RS, Silberstein SD. Development of a brief 24-hour migraine-specific quality of life questionnaire. Headache. 1995;35:320-329.
28. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622-629.
29. Cronbach LF. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-334.
30. Osterhaus JT, Townsend RJ, Gandek B, Ware JE Jr. Measuring the functional status and well-being of patients with migraine headache. Headache. 1994;34:337-343.